RE:RE:RE:Biodexa's CEO poof says, "In a way the Biodexa deal is Rathjen's Watson and Crick moment."
I agree. She's been a part of Bioasis
for over five years and shareholders have never had confidence that she knew enough about Bioasis, xB3 and the opportunities they present to actually do a good job. And when she took another job with Carina - wow! An explosion happened!
At the end of the day, what was important was whether potential biotech and pharmaceutical partners understood what xB3 was and what it's potential was. If Bioasis had ever engaged in serious drug development maybe these potential partners would have understood the value of xB3, and would have paid to be a part of it all.
But no. At long last, Ladenburg Thalmann, Lind, Midatech and Armistice have told Bioasis that they'll take this failure off of shareholders' hands, and that is the W&C moment, the helical structure augering in, well planned and described, but too late to allow shareholders to keep xB3, or even 10% of it.
You shouldn't say that this is DrDR's W&C moment. That's not a very flattering thing to say about her, but it may be the most truthful thing you have ever posted. Maybe you ought to stay with copy/pasting - banal, but safer for you.
JD Boomskid